3478-92-0 Usage
Uses
Used in Chemical Synthesis:
2-[2-(diMethylaMino)ethyl]aniline is used as an intermediate for synthesizing a range of dyes, pharmaceuticals, and other organic compounds, due to its unique chemical structure and reactivity.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-[2-(diMethylaMino)ethyl]aniline is used as a reagent in the preparation of heterocyclic compounds, which are essential building blocks for many medicinal agents.
Used in Catalysts:
2-[2-(diMethylaMino)ethyl]aniline serves as a catalyst in various chemical reactions, facilitating the process and improving the efficiency of the synthesis.
Used in Hair Dye Production:
2-[2-(diMethylaMino)ethyl]aniline is used in the production of hair dyes, where it contributes to the coloration and effectiveness of the product.
Used as a Colorant in Consumer Products:
2-[2-(diMethylaMino)ethyl]aniline is also used as a colorant in a variety of consumer products, adding visual appeal and enhancing the appearance of the items.
Safety Precautions:
It is crucial to handle 2-[2-(diMethylaMino)ethyl]aniline with care, as it is toxic and can cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use and storage to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 3478-92-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,7 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 3478-92:
(6*3)+(5*4)+(4*7)+(3*8)+(2*9)+(1*2)=110
110 % 10 = 0
So 3478-92-0 is a valid CAS Registry Number.
3478-92-0Relevant academic research and scientific papers
Orthoarylideneaminophenethylamines and pharmaceutical compositions
-
, (2008/06/13)
Compounds, exhibiting central nervous system activity, of the formula STR1 wherein R1 is phenyl which is unsubstituted or substituted by at least one member selected from the group consisting of halogen, CF3, C1 -C4 alkyl, C1 -C4 alkoxy and COOH, or R1 is STR2 or R1 is a heterocycle selected from the group consisting of STR3 R2 R3 R4 and R5, which may be identical or different, are H or CH3 ; R6 and R7, which may be identical or different, are C1 -C6 alkyl, which may be straight-chained or branched, or R7 can be H when R6 is a branched-chain alkyl, or R6 and R7 can form, with the nitrogen to which they are bonded, a heterocycle selected from the group consisting of STR4 R8 R9 R10 and R11, which may be identical or different, are H, halogen, CF3, hydroxy or C1 -C4 alkoxy, or two contiguous members of R8 R9, R10 and R11 may together form a chain --O--(CH2)n --O--, where n=1 or 2, or a chain --O--CH2 --O--CH2 --; and pharmaceutically acceptable addition salts thereof are disclosed, along with a method of producing the same, and pharmaceutical compositions comprising the same.
